Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive disease of progressive muscle weakness and wasting caused by the absence of dystrophin protein. Current gene therapy approaches using antisense oligonucleotides require lifelong dosing and have limited efficacy in restoring dystrophin production. A gene editing approach could permanently correct the genome and restore dystrophin protein expression. Here, we describe single-swap editing, in which an adenine base editor edits a single base pair at a splice donor site or splice acceptor site to enable exon skipping or reframing. In human induced pluripotent stem cell-derived cardiomyocytes, we demonstrate that single-swap editing can enable beneficial exon skipping or reframing for the three most therapeutically relevant exons—DMD exons 45, 51, and 53—which could be beneficial for 30% of all DMD patients. Furthermore, an adeno-associated virus delivery method for base editing components can efficiently restore dystrophin production locally and systemically in skeletal and cardiac muscles of a DMD mouse model containing a deletion of Dmd exon 44. Our studies demonstrate single-swap editing as a potential gene editing therapy for common DMD mutations.
Chai A.C., Chemello F., Li H., Nishiyama T., Chen K., Zhang Y., et al. (2023). Single-swap editing for the correction of common Duchenne muscular dystrophy mutations. MOLECULAR THERAPY NUCLEIC ACIDS, 32, 522-535 [10.1016/j.omtn.2023.04.009].
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
Chemello F.Co-primo
;
2023
Abstract
Duchenne muscular dystrophy (DMD) is a fatal X-linked recessive disease of progressive muscle weakness and wasting caused by the absence of dystrophin protein. Current gene therapy approaches using antisense oligonucleotides require lifelong dosing and have limited efficacy in restoring dystrophin production. A gene editing approach could permanently correct the genome and restore dystrophin protein expression. Here, we describe single-swap editing, in which an adenine base editor edits a single base pair at a splice donor site or splice acceptor site to enable exon skipping or reframing. In human induced pluripotent stem cell-derived cardiomyocytes, we demonstrate that single-swap editing can enable beneficial exon skipping or reframing for the three most therapeutically relevant exons—DMD exons 45, 51, and 53—which could be beneficial for 30% of all DMD patients. Furthermore, an adeno-associated virus delivery method for base editing components can efficiently restore dystrophin production locally and systemically in skeletal and cardiac muscles of a DMD mouse model containing a deletion of Dmd exon 44. Our studies demonstrate single-swap editing as a potential gene editing therapy for common DMD mutations.File | Dimensione | Formato | |
---|---|---|---|
2023-Chai-MTNA.pdf
accesso aperto
Tipo:
Versione (PDF) editoriale
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
5.16 MB
Formato
Adobe PDF
|
5.16 MB | Adobe PDF | Visualizza/Apri |
Single-swap editing for the correction of common Duchenne muscular dystrophy mutations.pdf
accesso aperto
Descrizione: Supplemental Information
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
5.03 MB
Formato
Adobe PDF
|
5.03 MB | Adobe PDF | Visualizza/Apri |
mmc2.xlsx
accesso aperto
Descrizione: Supplemental Information
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
11.91 kB
Formato
Microsoft Excel XML
|
11.91 kB | Microsoft Excel XML | Visualizza/Apri |
mmc3.xlsx
accesso aperto
Descrizione: Supplemental Information
Tipo:
File Supplementare
Licenza:
Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione
12.96 kB
Formato
Microsoft Excel XML
|
12.96 kB | Microsoft Excel XML | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.